Lung deposition of budesonide from Turbuhaler® is twice that from a pressurized metered-dose inhaler P-MDI

European Respiratory Journal

Volumn 7, Issue 10, 1994, Pages 1839-1844

  Thorsson, L ^a   Edsbacker, S ^a   Conradson, T B ^a  

^a Research and Development Department   (Sweden)

Author keywords

Budesonide; Lung deposition; Powder inhaler; Turbuhaler

Indexed keywords

BUDESONIDE;

ADULT; AEROSOL; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; FEMALE; HUMAN; HUMAN EXPERIMENT; INHALATION; LUNG; MALE; POWDER; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ADULT; BIOLOGICAL AVAILABILITY; BRONCHODILATOR AGENTS; BUDESONIDE; CHARCOAL; CROSS-OVER STUDIES; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; INTESTINAL ABSORPTION; LUNG; MALE; MIDDLE AGED; NEBULIZERS AND VAPORIZERS; PREGNENEDIONES;

EID: 0027986957     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.94.07101839     Document Type: Article

References (0)